Respiratory Support for the Severely Handicapped Child with Neuromuscular Disease: Ethics and Practicality

ABSTRACT

Recent respiratory developments have altered the management of children with severe neuromuscular disease, and in some cases changed the natural history of the conditions. These developments include improvements in diagnosis; a greater availability of ventilatory support techniques, including noninvasive modes; and better functional scoring systems that enable global muscle function and the impact of treatment to be evaluated. Greater choices can make for more difficult decision making, and the ability to prolong survival brings with it opportunities, but also ethical dilemmas. Clearer outcome information and assessment of the benefits and burdens of ventilatory support for the child and family should aid decision making. In many conditions there is no relationship between functional ability, the need for ventilatory support, and quality of life. Noninvasive ventilation combined with cough assistance is usually preferred to invasive ventilation and is likely to reduce respiratory morbidity. In situations where noninvasive ventilation does not extend survival, it may have a role in palliating symptoms and allowing the child to be cared for at home.

Noninvasive ventilation - Duchenne muscular dystrophy - spinal muscular atrophy - decision making - tracheostomy ventilation - palliative care

REFERENCES

• 1 Wallgren-Petterson C, Bushby K, Mellies U, Simonds A K. Ventilatory support in congenital neuromuscular disorders: congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA II.  Neuromuscul Disord. 2004;  14 56-69
• 2 Ragette R, Mellies U, Schwake C, Voit T, Teschler H. Patterns and predictors of sleep disordered breathing in primary myopathies.  Thorax. 2002;  57 724-728
• 3 Tomalak W, Pogorzelski A, Prusak J. Normal values for maximal inspiratory and expiratory pressures in healthy children.  Pediatr Pulmonol. 2002;  34 42-46
• 4 Rafferty G F, Leech S, Knight L, Moxham J, Greenough A. Sniff inspiratory pressure in children.  Pediatr Pulmonol. 2000;  29 468-475
• 5 Harikumar G, Greenough A, Rafferty G F. Respiratory muscle assessment in paediatric intensive care.  British Journal of Intensive Care. 2006;  16 59-63
• 6 Jeppesen J, Green A, Steffensen B F, Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use.  Neuromuscul Disord. 2003;  13 804-812
• 7 Baydur A, Gilgoff I, Prentice W, Carlson M, Fischer D A. Decline in respiratory function and experience with long term assisted ventilation in advanced Duchenne's muscular dystrophy.  Chest. 1990;  97 884-889
• 8 Bushby K, Muntoni F, Bourke J P. 107th International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy.  Neuromuscul Disord. 2003;  13 166-172
• 9 Duboc D, Meaune C, Lerebours G, Devaux J-Y, Vaksmann G, Becane H-M. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.  J Am Coll Cardiol. 2005;  45 855-857
• 10 Dubowitz V. Disorders of the lower motor neurone: the spinal muscular atrophies. In: V Dubowitz Muscle Disorders in Childhood. London; WB Saunders 1995: 325-367
• 11 Chung B HY, Wong V CN, Ip P. Spinal muscular atrophy: survival pattern and functional status.  Pediatrics. 2004;  114 e548-e553
• 12 Wong V, Wong S, Chan K, Wong W. Functional independence measure (WeeFIM) for Chinese children: Hong Kong cohort.  Pediatrics. 2002;  109 e36
• 13 Lyager S, Steffensen B, Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy.  Chest. 1995;  108 779-785
• 14 Thomas N H, Dubowitz V. The natural history of type I (severe) spinal muscular atrophy.  Neuromuscul Disord. 1994;  4 497-502
• 15 Consensus Conference. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a Consensus conference report.  Chest. 1999;  116 521-534
• 16 Raphael J-C, Chevret S, Chastang C, Bouvet F. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy.  Lancet. 1994;  343 1600-1604
• 17 Ward S, Chatwin M, Heather S, Simonds A K. Randomised controlled trial of noninvasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia.  Thorax. 2005;  60 1019-1024
• 18 Simonds A K. Risk management of the home ventilator dependent patient.  Thorax. 2006;  61 369-371
• 19 Fauroux B, Lavis J-F, Nicot F et al.. Facial side effects during noninvasive ventilation in children.  Intensive Care Med. 2005;  31 965-969
• 20 Bach J R, Baird J S, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: management and outcomes.  Pediatr Pulmonol. 2002;  34 16-22
• 21 Katz S, Selvadurai H, Mitchell M, MacLuskey I. Outcome of noninvasive positive pressure ventilation in paediatric neuromuscular disease.  Arch Dis Child. 2004;  89 121-124
• 22 Yates K, Festa M, Waters K, North K. Outcome of children with neuromuscular disease admitted to paediatric intensive care.  Arch Dis Child. 2004;  89 170-175
• 23 Tzeng A C, Bach J R. Prevention of pulmonary morbidity for patients with neuromuscular disease.  Chest. 2000;  118 1390-1396
• 24 Miske L J, Hickey E H, Kolb S M, Weiner D J, Panitch H B. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough.  Chest. 2004;  125 1406-1412
• 25 Toussaint M, Steens M, Wasteels G, Soudon P. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients.  Eur Respir J. 2006;  28 549-555
• 26 American Thoracic Society . Consensus statement: respiratory care of the patient with Duchenne muscular dystrophy.  Am J Respir Crit Care Med. 2004;  170 456-465
• 27 Lloyd-Owen S J, Donaldson G C, Ambrosino N et al.. Patterns of home mechanical use in Europe: results from the Eurovent survey.  Eur Respir J. 2005;  25 1025-1031
• 28 Ioos C, Leclair-Richard D, Mrad S, Barois A, Estournet-Mathiaud B. Respiratory capacity course in patients with infantile spinal muscular atrophy.  Chest. 2004;  126 831-837
• 29 Birnkrant D J, Pope J F, Martin J E, Repucci A H, Eiben R M. Treatment of type I spinal muscular atrophy with noninvasive ventilation and gastrostomy feeding.  Pediatr Neurol. 1998;  18 407-410
• 30 Bach J R, Niranjan V, Weaver B. Spinal muscular atrophy type I: a noninvasive respiratory management approach.  Chest. 2000;  117 1100-1105
• 31 Bush A, Fraser J, Jardine E, Paton J, Simonds A, Wallis C. Respiratory management of the infant with type I spinal muscular atrophy.  Arch Dis Child. 2005;  90 709-710
• 32 Bach J R, Vega J, Majors J, Friedman A. Spinal muscular atrophy type 1 quality of life.  Am J Phys Med Rehabil. 2003;  82 137-142
• 33 Daoud M S, Dooley J M, Gordon K E. Depression in parents of children with Duchenne muscular dystrophy.  Pediatr Neurol. 2004;  31 16-19
• 34 Laufersweiler-Plass C, Rudnik-Schoneborn S, Zerres K, Backes M, Lehmkuhl G, von Gontard A. Behavioural problems in children and adolescents with spinal muscular atrophy and their siblings.  Dev Med Child Neurol. 2003;  45 44-49
• 35 Hardart M KM, Burns J P, Truog R D. Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes.  Pediatrics. 2002;  110 e24
• 36 Hardart G E, Truog R D. Attitudes and preferences of intensivists regarding the role of family interests in medical decision making for incompetent patients.  Crit Care Med. 2003;  31 1895-1900
• 37 Gibson B. Long-term ventilation for patients with Duchenne muscular dystrophy: physicians' beliefs and practices.  Chest. 2001;  119 940-946
• 38 Kinali M, Manzur A Y, Gibson B E, Hartley L, Simonds A K, Muntoni F UK. Physicians' attitudes and practices of long-term noninvasive ventilation of children with Duchenne muscular dystrophy.  Pediatr Rehabil. 2006;  9 351-364
• 39 Sakakihara Y, Kubota M, Kim S, Oka A. Long-term ventilator support in patients with Werdnig-Hoffman disease.  Pediatr Int. 2000;  42 359-363
• 40 Hardart M KM, Truog R D. Spinal muscular atrophy type I: the challenge of defining the child's best interests.  Arch Dis Child. 2003;  88 848-850